Send Email
Call Anytime
X-twitter Facebook Linkedin Scopus icon

Competed projects

  1. Co-Principal Investigator (Co-PI)
    Project: Development of disinfection systems for the prevention and spread of COVID-19 through indoor air (2021)
    Funding Agency: BIRAC, India
  2. Principal Investigator
    Project: Development of Novel Benzo-Fused Heterocycles to Improve the Treatment of Drug-Resistant Tuberculosis (2021–2022)
    Funding Agency: DBT, India
  3. Principal Investigator
    Project: To study the role of mesenchymal stem cells in the pathogenesis of tuberculosis in bone marrow (2017–2022)
    Funding Agency: DBT, India
  4. Principal Investigator
    Project: Pharmacological evaluation of a novel asparaginase used for the treatment of acute lymphoblastic leukemia (ALL) (2018–2022)
    Funding Agency: BRNS, India
  5. Co-Leader, Centre of Excellence
    Project: Centre of Excellence on “Translational Research Program on Gastrointestinal Bacterial Pathogens” (2015–2020)
    Funding Agency: DBT, India
  6. Principal Investigator
    Project: Development of theranostic targeted magnetic nanoparticles for diagnostics and treatment of tuberculosis (2020–2022)
    Funding Agency: Indo-Russia (DST–RFBR)
  7. Principal Investigator (BIG Innovation Grant)
    Project: Development of novel asparaginase-based therapy for the treatment of acute lymphatic leukemia (2016–2018)
    Funding Agency: BIRAC, DBT, India
  8. Principal Investigator
    Project: Evaluation of antileukemic and immunogenicity properties of engineered Escherichia coli asparaginase-II for the treatment of acute lymphoblastic leukemia in preclinical models (2015–2018)
    Funding Agency: DST, India
  9. Principal Investigator
    Project: Identification and testing of cationic antimicrobial peptides from human granulocytes against mycobacteria: implications for polypeptide-based therapy for tuberculosis (2013–2016)
    Funding Agency: DBT, India
  10. Principal Investigator
    Project: Delivery of drug-encapsulating nanoparticles to macrophages and their role in the induction of innate and adaptive immune responses for the treatment of tuberculosis (2013–2016)
    Funding Agency: DST, India
  11. Principal Investigator
    Project: Identification and elucidation of the role of glycoproteins in the pathogenesis of Mycobacterium tuberculosis: implications for modulation of host immune responses and drug targets (2012–2015)
    Funding Agency: ICMR, India
  12. Principal Investigator
    Project: Nanobead-based novel strategies for the efficient delivery of drug molecules for the treatment of tuberculosis (2010–2014)
    Funding Agency: DBT, India
  13. Principal Investigator
    Project: Improving the properties of L-asparaginase used for the treatment of acute lymphatic leukemia (2010–2013)
    Funding Agency: DST, India
  14. Principal Investigator
    Project: Construction of Mycobacterium tuberculosis glum mutants by site-directed mutagenesis (2010)
    Funding Agency: OSDD, CSIR

MFS-Department of Biosciences and Biomedical Engineering,

Links

Contact

  • © Copyright 2025